Wednesday, January 18, 2017

BRIEF-Jazz Pharmaceuticals comments on FDA nod for generic version of Xyrem

* Jazz Pharmaceuticals says it will evaluate FDA's waiver of

requirement for a single, shared system rems in connection with

approval of a generic version of Xyrem

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)